Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;1(2):103-112.
doi: 10.1016/j.imj.2022.06.005. Epub 2022 Jun 26.

Mapping the intersection of nanotechnology and SARS-CoV-2/COVID-19: A bibliometric analysis

Xuejuan Zhang  1 , Mengqin Guo  1 , Zhengwei Huang  1 , Ying Huang  1 , Chuanbin Wu  1 , Xin Pan  2
Affiliations

Mapping the intersection of nanotechnology and SARS-CoV-2/COVID-19: A bibliometric analysis

Xuejuan Zhang et al. Infect Med (Beijing). 2022 Jun.

Abstract

Background: Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has imposed great medical and economic burdens on human society, and nanotechnology is a promising technique for managing the ongoing COVID-19 pandemic. To drive further studies on anti-COVID-19 nanotechnology, this paper provides an analysis, from a bibliometric perspective, of the intersection of nanotechnology and SARS-CoV-2/COVID-19.

Methods: We analyzed the 2585 publications on nanotechnology and SARS-CoV-2/COVID-19 included in the Web of Science Core Collection from January 2019 to March 2022 to determine the bibliometric landscape. The basic bibliometric characteristics are summarized in this article.

Results: Our bibliometric analysis revealed that the intersection between nanotechnology and SARS-CoV-2/COVID-19 is a cutting-edge field in the science community and that the related studies were multidisciplinary in nature. Studies on the structural basis of SARS-CoV-2, SARS-CoV-2 detection assays, and mRNA vaccines against COVID-19 provided the development foundation for this field.

Conclusions: The current research focuses are the development of nanomaterial-based vaccines and SARS-CoV-2 detection methods, and the design of nanomedicines carrying SARS-CoV-2 inhibitors is a relatively burgeoning frontier. In summary, this bibliometric analysis of the intersection of nanotechnology and SARS-CoV-2/COVID-19 highlights the current research focuses of this field to inspire future studies on anti-COVID-19 nanotechnologies.

Keywords: Bibiometric analysis; COVID-19; Coronavirus disease 2019, COVID-19; Nano technology; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2; Web of Science.

PubMed Disclaimer

Figures

Image, graphical abstract
Graphical abstract
Scheme 1
Scheme 1
Flowchart scheme of this bibliometric review.
Fig. 1
Fig. 1
Demographics of the 2585 documents. (A) Indexed database; (B) Publication year; (C) Document type; (D) Language; (E) Citation performance by year.
Fig. 2
Fig. 2
Co-authorship of the 2585 documents. (A) Countries/regions; (B) Organizations.
Fig. 3
Fig. 3
Co-authorship of the 2585 documents, in terms of researchers. (A) Full data set; (B) Magnification of the partial network of the red oval region in (A).
Fig. 4
Fig. 4
Bibliographic information of the 2585 documents. (A) Clustered co-citation visualization; (B) Time-overlay bibliographic coupling visualization.
Fig. 5
Fig. 5
Keyword co-occurrence of the 2585 documents. (A) Clustered visualization; (B) Time-overlay visualization.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Yuki K., Fujiogi M., Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020;215 - PMC - PubMed
    1. Shi Y., Wang G., Cai X.-p., et al. An overview of COVID-19. J Zhejiang Univ-SCIENCE B. 2020;21:343–360. - PMC - PubMed
    1. Burki T.K. Omicron variant and booster COVID-19 vaccines. Lancet Respir Med. 2022;10:e17. - PMC - PubMed
    1. Sudhakar M., Winfred S.B., Meiyazhagan G., et al. Mechanisms contributing to adverse outcomes of COVID-19 in obesity. Mol Cell Biochem. 2022;477:1–39. - PMC - PubMed
    1. Yin Y., Su W., Zhang J., et al. Separable microneedle patch to protect and deliver DNA nanovaccines against COVID-19. Acs Nano. 2021;15:14347–14359. - PubMed